Drug Development Research

Papers
(The H4-Index of Drug Development Research is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR ‐153‐3p/ ATF2 axis and81
Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect76
Trifolirhizin targets PTK6 to induce autophagy and exerts antitumor effects in nasopharyngeal carcinoma61
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini‐pigs59
Research Progress of Endoplasmic Reticulum Targeting Metal Complexes in Cancer Therapy49
Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains45
A growth‐based assay using fluorescent protein emission to screen for S‐adenosylmethionine synthetase inhibitors43
Terbutaline attenuates LPS ‐induced injury of pulmonary microvascular endothelial cells by cAMP /Epac signaling40
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment40
Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c‐Jun Pathway38
Targeting TRAF3IP2 alleviates high glucose‐induced cardiomyocyte inflammation and apoptosis34
Therapeutic potential and research progress of diosgenin for lipid metabolism diseases33
Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone‐based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease28
Issue Information26
Anti‐inflammatory effect and mechanism of catalpol in various inflammatory diseases26
Recent research brings hope for reshaping the co‐evolutionary arms race against parasitic infectious diseases25
Issue Information25
Reduction‐Responsive RGD‐Docetaxel Conjugate: Synthesis, In Vitro Drug Release and In Vitro Antitumor Activity23
T‐17, a novel cyclin‐dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis23
The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐222
Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation21
0.12895011901855